A Search Service for Abbreviation / Long Form

■ Search Result - Abbreviation : 6-MP

Search Conditions:
Search Keyword : 6-MP
Search Method : Exact match.
Research Area:

Results:  
Abbreviation: 6-MP
Appearance Frequency: 1026 time(s)
Long forms: 17

Display Settings:
[Entries Per Page]
 per page
Page Control
Page: of
Long Form No. Long Form Research Area Co-occurring Abbreviation PubMed/MEDLINE Info. (Year, Title)
6-mercaptopurine
(989 times)
Neoplasms
(183 times)
ALL (192 times)
AZA (151 times)
TPMT (129 times)
1957 Effect of 6-mercaptopurine (6-MP) on the serum level of vitamin B12 in leukemia.
6-methylprednisolone
(10 times)
Neurology
(3 times)
CORT (2 times)
DEX (2 times)
PROG (2 times)
1982 [Quantitative-cytochemical evaluation of acid phosphatase activity in skin window macrophages (author's transl)].
6-mercaptopurine monohydrate
(5 times)
Pediatrics
(1 time)
4-MBA (1 time)
4-MPy (1 time)
ACHN (1 time)
1984 Further studies on 6-mercaptopurine-induced muscle atrophy in rats, mice, and hamsters treated as neonates.
6-methylpurine
(5 times)
Genomics
(2 times)
5-FOA (2 times)
6-MPDR (1 time)
AMD (1 time)
1976 Effects of inhibitors of RNA and protein synthesis on aspartate transcarbamylase activity in etiolated plant tissue.
6-methylene-4-pregnene-3,20-dione
(4 times)
Pharmacology
(1 time)
4-HA (1 time)
BUG (1 time)
CG (1 time)
1988 The effects of an aromatase inhibitor and a 5 alpha-reductase inhibitor upon the occurrence of polyovular follicles, persistent anovulation, and permanent vaginal stratification in mice treated neonatally with testosterone.
more potently than 6-mecaptopurine
(2 times)
Chemistry
(1 time)
5-ASA (1 time)
IBD (1 time)
YNBY (1 time)
2008 2-Arylbenzimidazoles as antiviral and antiproliferative agents. Part 1.
2-O-pivaloyl-(2-MP)-, 6-O-pivaloyl
(1 time)
Biochemistry
(1 time)
BNPP (1 time)
1995 Catalytic properties of rabbit serum esterases hydrolyzing esterified monosaccharides.
6-alpha-methylprednisolone
(1 time)
Clinical Laboratory Techniques
(1 time)
CAH (1 time)
LC-MS (1 time)
MS (1 time)
2005 Determination of 17alpha-hydroxyprogesterone in serum by liquid chromatography-tandem mass spectrometry and immunoassay.
6-megapixel
(1 time)
Dentistry
(1 time)
DICOM (1 time)
2015 Comparison between DICOM-calibrated and uncalibrated consumer grade and 6-MP displays under different lighting conditions in panoramic radiography.
10  6-mercaptoethanol
(1 time)
Gastroenterology
(1 time)
ADSS (1 time)
ATP (1 time)
ATPase (1 time)
2011 Inosine triphosphate protects against ribavirin-induced adenosine triphosphate loss by adenylosuccinate synthase function.
11  6-methyleneprogesterone
(1 time)
Urology
(1 time)
DHT (1 time)
1986 The dihydrotestosterone (DHT) hypothesis of prostate cancer and its therapeutic implications.
12  6-mono-6-MP prodrugs to deliver 6-mercaptopurine
(1 time)
Pharmacology
(1 time)
6,9-bis-6-MP (1 time)
6-mono-6-MP (1 time)
9-mono-6-MP (1 time)
1988 Effects of vehicles and prodrug properties and their interactions on the delivery of 6-mercaptopurine through skin: S6-acyloxymethyl-6-mercaptopurine prodrugs.
13  amino-6-mercaptopurine
(1 time)
Microbiological Phenomena
(1 time)
AIEC (1 time)
CD (1 time)
2018 Phagocytosis and Epithelial Cell Invasion by Crohn's Disease-Associated Adherent-Invasive Escherichia coli Are Inhibited by the Anti-inflammatory Drug 6-Mercaptopurine.
14  maintenance phase with daily 6-mercaptopurine
(1 time)
Neoplasms
(1 time)
6-MMP (1 time)
ALL (1 time)
GI (1 time)
2020 Use of Allopurinol to Mitigate 6-Mercaptopurine Associated Gastrointestinal Toxicity in Acute Lymphoblastic Leukemia.
15  maintenance phase, 6-mercaptopurine
(1 time)
Genomics
(1 time)
ALL (1 time)
DHFR (1 time)
ITPA (1 time)
2017 The Promise of Pharmacogenomics in Reducing Toxicity During Acute Lymphoblastic Leukemia Maintenance Treatment.
16  measuring plasma concentrations of 6-mercaptopurine
(1 time)
Drug Therapy
(1 time)
HPLC (1 time)
mBrB (1 time)
1993 A sensitive high-performance liquid chromatographic method for the determination of 6-mercaptopurine in plasma using precolumn derivatization and fluorescence detection.
17  modification potential of 6-mercaptopurine
(1 time)
Neoplasms
(1 time)
DEN (1 time)
PB (1 time)
1992 Lack of modifying effects of 6-mercaptopurine in a medium term bioassay system for liver carcinogenesis using male F344 rats.